Unlicensed/Off-Label Drug Prescriptions at Hospital Discharge in Children: An Observational Study Using Routinely

Elham Jaberi1, Inesse Boussaha2, Xavier Dode3

  • 1UMR CNRS 5558, Laboratoire de Biométrie et Biologie Humaine, Équipe Évaluation et Modélisation des Effets Thérapeutiques, rue Guillaume-Paradin, BP8071, CEDEX 08, F-69376 Lyon, France.

PubMed

Insights

Nearly 40% of pediatric hospital discharge prescriptions in France were unlicensed or off-label (UL/OL). Younger children and those with more medications were more likely to receive UL/OL prescriptions, increasing drug-related problem risks.

Area of Science:

  • Pediatric Pharmacology
  • Drug Safety
  • Health Outcomes Research

Background:

  • Unlicensed and off-label (UL/OL) prescriptions are linked to increased drug-related problems.
  • Limited data exists on the prevalence of UL/OL drug use at hospital discharge.
  • This study addresses the gap in understanding UL/OL prescription patterns in pediatric patients upon discharge.

Purpose of the Study:

  • To determine the prevalence of unlicensed and off-label (UL/OL) drugs in outpatient prescriptions at pediatric hospital discharge.
  • To identify characteristics and predictors associated with UL/OL prescriptions in children.

Main Methods:

  • Retrospective analysis of routinely collected health data from pediatric hospital discharges (2014-2016).
  • Utilized French industry-independent formulary Thériaque (summaries of product characteristics) to define licensed labeling.
  • Described UL/OL prescription characteristics and analyzed predictors.

Main Results:

  • 2536 prescriptions from 479 children were analyzed.
  • Off-label (OL) prescriptions were 39.2% and unlicensed (UL) prescriptions were 2.3%, with 74% of children receiving at least one UL/OL drug.
  • Younger age and a higher number of prescribed drugs were significant predictors of UL/OL prescriptions.

Conclusions:

  • Approximately 40% of pediatric hospital discharge prescriptions in France involve unlicensed or off-label (UL/OL) medications.
  • The high prevalence highlights potential risks and the need for careful monitoring in pediatric pharmacotherapy.
  • Younger children and those with polypharmacy represent a vulnerable group for UL/OL prescribing.
Abstract

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
734
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
835
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Discharge Summary Forms01:31

Discharge Summary Forms

The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
757
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
148
Drug Classes and Categories01:25

Drug Classes and Categories

Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.0K